Elmiron, the first oral therapy for interstitial cystitis

November 1996

You'll see a lot of publicity for Elmiron, the first oral therapy for interstitial cystitis.

This incurable inflammatory bladder condition affects up to half a million people...primarily women.

It causes SEVERE pain and urinary frequency...similar to the symptoms caused by a severe bladder infection.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

More prescriptions will be transmitted electronically
new asthma drug, Accolate (zafirlukast)
The FDA is about to switch Nasalcrom (cromolyn) to OTC
Neurology & Pain Neurontin (gabapentin) for pain
Substance Use Disorder DEA would control sales of OTC pseudoephedrine (Sudafed, etc)
Substance Use Disorder cases of clonidine abuse
STIs emerging resistance of gonorrhea to quinolone antibiotics
Infectious Diseases higher-strength form of Retrovir (zidovudine, AZT)
Infectious Diseases Valtrex (valacyclovir) for treating INITIAL episodes of genital herpes
Infectious Diseases more patients getting prednisone for shingles
Cardiology alternatives to warfarin to prevent ischemic stroke in patients with atrial fibrillation (AF)
Cardiology stop using nifedipine capsules to lower extremely high blood pressure
Renal & Urology Elmiron, the first oral therapy for interstitial cystitis
Vaccines more emphasis on COMBINING pediatric vaccines
Vaccines COMBINE Connaught's ActHIB with Tripedia (DTaP) so they can be given together in one injection
Antipsychotics You're going to hear LOTS about Zyprexa (olanzapine)